Bitech Technologies CORP Form 4 insider transactions

Cole Wayne Johnson, Director and Co-CEO of Bimergen Energy Corp, acquired 100,000 shares of common stock via options exercise on April 30, 2026.

Bimergen Energy Corp Director Van H Potter acquired 25,000 shares through an option exercise on April 30, 2026.

Robert J. Brilon, Co-CEO and CFO of Bimergen Energy Corp, acquired 100,000 stock options.

Bimergen Energy Corp director James L. Stock acquired 25,000 stock options, indicating a potential future investment in the company.

Montgomery Bannerman, a Director at Bimergen Energy Corp (BESS), reported the acquisition of 25,000 stock options.

Bimergen Energy Corp director Benjamin Tran acquired 50,000 stock options with an exercise price of $2.51, exercisable from April 30, 2026, to April 30, 2036.

Black Titan Corporation announced the successful closing of its merger with Titan Pharmaceuticals, Inc., with the combined entity now trading on Nasdaq under the ticker BTTC.

Black Titan Corporation announced the successful closing of its merger with Titan Pharmaceuticals, Inc., with the combined entity now trading on Nasdaq under the ticker BTTC.

Bimergen Energy Corp's President, Cole Wayne Johnson, had his stock options repriced to a higher exercise price of $4.50 per share by the Board of Directors.

Bimergen Energy Corp Director James L. Stock reported the acquisition of 45,000 stock options with an exercise price of $4.50, vesting over three years.

Bimergen Energy Corp's CEO, Benjamin Tran, had 142,858 stock options repriced to an exercise price of $4.50 per share by the Board of Directors.

Bimergen Energy Corp's Director and 10% Owner, Montgomery L. Bannerman, acquired 45,000 stock options with an exercise price of $4.50.

Bimergen Energy Corp director Van H Potter reported the acquisition of 45,000 stock options with a $4.5 exercise price, vesting over three years.

Bimergen Energy Corp's CFO and Director, Robert J. Brilon, received a new grant of 210,000 stock options and had 71,429 existing options repriced to a higher exercise price of $4.50 per share.

Robert J. Brilon, CFO of Bitech Technologies Corp, reports the acquisition of 10,000,000 options on May 3, 2024, with exercise prices ranging from $0.50 to $1.50 and vesting over five years.

Bitech Technologies CEO Benjamin Tran was granted 20,000,000 options to purchase common stock, exercisable in tranches over five years at prices ranging from $0.50 to $1.50.

Benjamin Tran, CEO of Bitech Technologies Corp, reports the acquisition of 2,000,000 shares of common stock at $0.05 per share on December 1, 2023.